Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tareq M I Salah, M.D.

Concepts (59)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Electrons120232690.840 Why?
Radiotherapy, Conformal120235480.720 Why?
Saudi Arabia420232090.360 Why?
Phlebitis12023300.230 Why?
Receptor, erbB-23202123700.210 Why?
Neoadjuvant Therapy3202126880.190 Why?
Candidiasis, Vulvovaginal12019240.180 Why?
Receptors, Progesterone2202110940.170 Why?
Yeasts120192850.160 Why?
Radiotherapy, Adjuvant1202317710.160 Why?
Receptors, Estrogen2202121830.140 Why?
Diabetes Mellitus, Type 232023116990.130 Why?
Antifungal Agents120197220.120 Why?
Vagina120198220.120 Why?
Carcinoma, Transitional Cell120197780.110 Why?
Adrenal Cortex Hormones1201918330.090 Why?
Carcinoma1202023610.080 Why?
Obesity22023126430.080 Why?
Breast Neoplasms32021206760.080 Why?
Weight Loss3202325890.080 Why?
Life Style3202338170.070 Why?
Urinary Bladder Neoplasms1201921960.070 Why?
Saline Solution, Hypertonic120231100.050 Why?
Erythema120232540.050 Why?
Body Mass Index12019126550.050 Why?
Disease-Free Survival2202168710.050 Why?
Keratin-512019470.040 Why?
Cyclin B112019510.040 Why?
Prognosis42021289010.040 Why?
Edema120237910.040 Why?
Receptor, Fibroblast Growth Factor, Type 3120191050.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019114100.040 Why?
Infusions, Intravenous1202322700.040 Why?
Middle Aged520232128630.040 Why?
Antineoplastic Agents12020136350.040 Why?
Survival Rate22020127610.030 Why?
Carcinoma, Lobular120194820.030 Why?
In Situ Hybridization, Fluorescence1202126340.030 Why?
Humans1020237393980.030 Why?
Female620233788530.030 Why?
Young Adult42021562550.030 Why?
Chemotherapy, Adjuvant1202034530.030 Why?
Carcinoma, Ductal, Breast1201911000.020 Why?
Tumor Suppressor Protein p531201929480.020 Why?
Recurrence1201983070.020 Why?
Longitudinal Studies12023138800.020 Why?
Survival Analysis12019102470.020 Why?
Adult420212133940.020 Why?
Immunohistochemistry12019113470.020 Why?
Age Factors12019183490.010 Why?
Retrospective Studies22020766310.010 Why?
Incidence12019209130.010 Why?
Cross-Sectional Studies12019247140.010 Why?
Time Factors12019400500.010 Why?
Aged220201626980.010 Why?
Follow-Up Studies12019389420.010 Why?
Prospective Studies12019530370.010 Why?
Aged, 80 and over12019576500.010 Why?
Male120193490220.000 Why?
Salah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (59)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.